Peer-reviewed veterinary case report
Ultrasonic nasal tumor treatment helped 2 dogs breathe better
By Mizutani, Shinya et al.·Published in The Canadian veterinary journal = La revue veterinaire canadienne·2025·Faculty of Veterinary Medicine, Japan·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Usefulness of transnasal volume-reduction treatment for nasal tumors by ultrasonic emulsification suction in 2 dogs.
- Species:
- dog
Plain-English summary
A 7-year-old mixed-breed dog and a 10-year-old Labrador were both brought in for nasal tumors, which caused symptoms like nosebleeds and difficulty breathing. Since traditional radiation therapy wasn't an option for them, veterinarians used a new method called transnasal volume-reduction treatment to shrink the tumors. About a week after the procedure, both dogs showed significant improvement in their breathing and overall activity levels, although the tumors did come back later. This treatment helped enhance their quality of life without any major complications, making it a viable option for dogs with similar issues.
People also search for: dog nasal tumor treatment · why is my dog having nosebleeds · dog breathing problems · palliative care for dog tumors
Abstract
Intranasal tumors in dogs are rare neoplastic diseases with obvious clinical signs, such as epistaxis, nasal congestion, and facial deformity. Radiation therapy is the treatment of choice but is not always accessible due to geographical location, logistics, or financial constraints. Other treatments may not be used because of various restrictions. We performed transnasal intranasal tumor volume reduction in 2 dogs with intranasal tumors; 1 dog had an adenocarcinoma and the other had a fibrosarcoma. In both cases, improvement in the quality of life (QOL), including reduced clinical signs and increased activity, was observed ~1 wk after treatment. No obvious complications were associated with this treatment. Although tumor recurrence was noted in both cases, this treatment could be applied multiple times. In conclusion, transnasal nasal tumor volume reduction is a palliative method that contributes to improvement of clinical signs and QOL. Key clinical message: We report palliative treatment of intranasal tumors in dogs. The treatment described in this report is available to most veterinarians and helps improve the QOL of dogs with nasal tumors, including improving respiratory status.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/40070945/